Crystal structure of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor

Citation
A. Mac Sweeney et al., Crystal structure of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor, ACT CRYST D, 56, 2000, pp. 280-286
Citations number
33
Categorie Soggetti
Chemistry & Analysis
Journal title
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
ISSN journal
09074449 → ACNP
Volume
56
Year of publication
2000
Part
3
Pages
280 - 286
Database
ISI
SICI code
0907-4449(200003)56:<280:CSODBT>2.0.ZU;2-K
Abstract
Chymotrypsin is a member of the trypsin family of serine proteases and is o ne of the first proteins successfully studied by X-ray crystallography. It is secreted into the intestine as the inactive precursor chymotrypsinogen; four sequential cleavages of the peptide bonds following residues 13, 15, 1 46 and 148 occur to generate the active pi, delta, kappa and alpha forms of chymotrypsin. C-13 NMR has shown [O'Connell & Malthouse (1995). Biochem. J , 307, 353-359] that when the delta form of chymotrypsin is inhibited by 2- C-13-enriched benzyloxycarbonylglycylglycylphenylalanyl chloromethane, a te trahedral adduct is formed which is thought to be analogous to the tetrahed ral intermediate formed during catalysis, This inhibitor complex has bean c rystallized as a dimer in space group P4(1)2(1)2. The structure has been re fined at 2.14 Angstrom resolution to an R value of 21.2% (free R = 25.2%), Conformational differences between delta-chymotrypsin and chymotrypsinogen in the region of the flexible autolysis loop (residues 145-150) were observ ed. This is the first crystal structure of S-chymotrypsin and includes two residues which are disordered in previous crystal structures of active chym otrypsin. A difference of 11.3 Angstrom(2) between the average Zz values of the monomers within the asymmetric unit is caused by lattice-disordering e ffects approximating to rotation of the molecules about a crystallographic screw axis, The substrate-binding mode of the inhibitor was similar to othe r chymotrypsin peptidyl inhibitor complexes, but this is the first publishe d chymotrypsin structure in which the tetrahedral chloromethyl ketone trans ition-state analogue is observed, This structure is compared with that of a similar tetrahedral transition-state analogue which does not alkylate the active-site histidine residue.